Esperion
Cardiometabolic Therapeutics · Prescription Drugs

Esperion: Ownership & structure

Esperion operates through 1 legal entity in 1 country.

Data updated Nov 22, 2026 · Back to the company report

Owners & entities

Esperion operates through 1 legal entity in 1 country.

Legal entities1 in 1 country
Esperion Therapeutics, Inc.
operator
US
Large holders (13D / 13G)holders of 5% or more, their newest filing
GOLDMAN SACHS GROUP INC
passive holder · SCHEDULE 13G/A · Nov 2026
VANGUARD CAPITAL MANAGEMENT LLC
passive holder · SCHEDULE 13G · Jul 2026
WASATCH ADVISORS LP
passive holder · SCHEDULE 13G/A · Jul 2026
GLAZER CAPITAL, LLC
passive holder · SCHEDULE 13G · Jun 2026
VANGUARD GROUP INC
passive holder · SCHEDULE 13G/A · Mar 2026
Two Seas Capital LP
passive holder · SCHEDULE 13G/A · Nov 2025
BB BIOTECH AG
passive holder · SCHEDULE 13G/A · Mar 2025
Insider tradesopen-market buys and sales on SEC Form 4, last 12 months

Insiders bought $0 (0 people) and sold $576k (3 people) in the last 12 months.

Sold · President and CEO
53,588 shares at $3.16 · Jun 2026
$169k
Sold · Chief Legal Officer
11,824 shares at $3.16 · Jun 2026
$37k
Sold · Chief Financial Officer
10,773 shares at $3.16 · Jun 2026
$34k
Sold · President and CEO
25,578 shares at $2.72 · Mar 2026
$70k
Sold · Chief Financial Officer
6,424 shares at $2.71 · Mar 2026
$17k
Sold · Chief Legal Officer
5,708 shares at $2.70 · Mar 2026
$15k
Sold · General Counsel
1,689 shares at $2.88 · Jan 2026
$4.9k
Sold · President and CEO
48,244 shares at $3.67 · Dec 2025
$177k
Sold · Chief Financial Officer
7,337 shares at $3.67 · Dec 2025
$27k
Sold · General Counsel
6,517 shares at $3.67 · Dec 2025
$24k
Holders and shares as each register or filing states them.

Connections

Connections

List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors4
ARCHIMEDVia a fund
53 portfolio companies: Organika Health Products, 3verest, Genetica Bioscience and 50 more
78 portfolio companies: Zenas BioPharma, Mobia Medical, Inc. and 76 more
Aisling CapitalVia a fund
117 portfolio companies: CoolSculpting, Zosanopharma, Shofsky and 114 more
168 portfolio companies: Zayo Group, yoyi.com.cn, IgniteTech and 165 more
Show all 4